[Clinical application of mifepristone in obstetrics and gynecology]

L Weng, Weng L
Zhonghua fu chan ke za zhi · 1999 · vol. 34(5) , pp. 261–4 · PMID:11326928
Other public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-05 ⓘ

The paper discusses the clinical application of mifepristone in obstetrics and gynecology, though no specific findings or abstract details are available to summarize.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Abortifacient Agents, Steroidal Leiomyoma Mifepristone Uterine Neoplasms Abortifacient Agents, Steroidal Abortifacient Agents, Steroidal Contraceptives, Postcoital, Synthetic Contraceptives, Postcoital, Synthetic Endometriosis Endometriosis Endometriosis Female Female Humans Humans Leiomyoma Leiomyoma Mifepristone Mifepristone Pregnancy

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T20:59:53.382863+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine